- Presentations
- 2
- Markets
- 1
Gleevec is a brand of Imatinib marketed by Novartis Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Imatinib
- Brand owner
- Novartis Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 100 mg tablet, 400 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Gleevec 100 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Gleevec 400 mg tabletOral | Novartis Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Imatinib.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Gleevec
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.